Andrew Connor Dierk
About Andrew Connor Dierk
Andrew Connor Dierk is the Associate Director of Patient Access and Support Services at Bristol Myers Squibb, with extensive experience in patient support and healthcare roles.
Company
Andrew Connor Dierk is currently employed at Bristol Myers Squibb, where he holds the position of Associate Director, Patient Access and Support Services. Bristol Myers Squibb is a renowned biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.
Title
Andrew Connor Dierk serves as Associate Director, Patient Access and Support Services at Bristol Myers Squibb. His role focuses on enhancing patient access to necessary medications and providing robust support services tailored to patient needs.
Education and Expertise
Andrew Connor Dierk earned a Master of Science (MS) in Biotechnology Enterprise and Entrepreneurship from The Johns Hopkins University between 2018 and 2020. Prior to that, he achieved a Bachelor of Science (BS) in Biology from Dickinson College, where he studied from 2012 to 2014. His foundational education began at Susquehanna University, where he also studied Biology from 2010 to 2012.
Professional Background
Andrew Dierk's career includes a broad array of roles within both the healthcare and technology sectors. At Bristol Myers Squibb, he advanced from Senior Manager to Manager positions before becoming Associate Director. Previously, he was at Otsuka Pharmaceutical Companies (U.S.), where he served as a Neuroscience Account Manager handling District Business Analytic Tech Point duties. His earlier roles include Major Gifts Coordinator at Atlantic Health, Cloud and Infrastructure Account Executive at Oxford Networks, and Community Health Policy Fellow at Partnership For Better Health.
Early Career Experience
Andrew Connor Dierk gained valuable early career experience through various internships and fellowships. He was a Community Health Policy Fellow at Partnership For Better Health, focusing on health policy initiatives. He completed summer internships at Memorial Sloan-Kettering Cancer Center, gaining exposure to cancer research and treatment. Additionally, he interned in the Formulations Department at ImClone Systems, a subsidiary of Eli Lilly and Company, where he gained hands-on experience in pharmaceutical formulations.